Related references
Note: Only part of the references are listed.The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
P. Gergely et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Synthetic Sphingosine 1-Phosphate Receptor Modulators - Opportunities and Potential Pitfalls
Martin H. Bolli et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients
James B. Moberly et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Mechanisms of Fingolimod's Efficacy and Adverse Effects in Multiple Sclerosis
Jeffrey A. Cohen et al.
ANNALS OF NEUROLOGY (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
Betty Soliven et al.
NEUROLOGY (2011)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sphingosine-1-phosphate receptor signalling in the heart
Christopher K. Means et al.
CARDIOVASCULAR RESEARCH (2009)
FTY720: Placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects
Robert Schmouder et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cell type-specific localization of human cardiac S1P receptors
D Mazurais et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Share Paper
